These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32353313)

  • 21. Smoking Water-Pipe, Opium Use and Prevalence of Heart Disease: A Cross-sectional Analysis of Baseline Data from the Pars Cohort Study, Southern Iran.
    Adib A; Masoompour SM; Molavi Vardanjani H; Gondomkar A; Poustchi H; Salehi A; Islami F; Malekzadeh R
    Arch Iran Med; 2020 May; 23(5):289-295. PubMed ID: 32383612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opium use as an independent risk factor for pancreatic cancer: A case-control study.
    Naghibzadeh-Tahami A; Marzban M; Yazdi-Feyzabadi V; Khazaei Z; Zahedi MJ; Moazed V; Haghdoost AA
    Cancer Epidemiol; 2021 Dec; 75():102017. PubMed ID: 34626910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lead poisoning among opium users in Iran: an emerging health hazard.
    Hayatbakhsh MM; Oghabian Z; Conlon E; Nakhaee S; Amirabadizadeh AR; Zahedi MJ; Darvish Moghadam S; Ahmadi B; Soroush S; Aaseth J; Mehrpour O
    Subst Abuse Treat Prev Policy; 2017 Oct; 12(1):43. PubMed ID: 28982369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.
    Shakeri R; Kamangar F; Mohamadnejad M; Tabrizi R; Zamani F; Mohamadkhani A; Nikfam S; Nikmanesh A; Sotoudeh M; Sotoudehmanesh R; Shahbazkhani B; Ostovaneh MR; Islami F; Poustchi H; Boffetta P; Malekzadeh R; Pourshams A
    Medicine (Baltimore); 2016 Jul; 95(28):e3922. PubMed ID: 27428185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.
    Khademi H; Malekzadeh R; Pourshams A; Jafari E; Salahi R; Semnani S; Abaie B; Islami F; Nasseri-Moghaddam S; Etemadi A; Byrnes G; Abnet CC; Dawsey SM; Day NE; Pharoah PD; Boffetta P; Brennan P; Kamangar F
    BMJ; 2012 Apr; 344():e2502. PubMed ID: 22511302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran.
    Naghibzadeh Tahami A; Khanjani N; Yazdi Feyzabadi V; Varzandeh M; Haghdoost AA
    Arch Iran Med; 2014 Jan; 17(1):2-6. PubMed ID: 24444058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is opium use associated with an increased risk of lung cancer? A case-control study.
    Naghibzadeh-Tahami A; Marzban M; Yazdi-Feyzabadi V; Dabiri S; Mohseni S; Abbasi Rayeni R; Samareh Fekri M; Larizadeh MH; Karimpour B; Khanjani N
    BMC Cancer; 2020 Aug; 20(1):807. PubMed ID: 32842991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opium and Cigarette Smoking are Independently Associated with Bladder Cancer: The Findings of a Matched Case - Control Study.
    Abdolahinia Z; Pakmanesh H; Mirzaee M; Bazrafshan A; Shafiei Bafti M; Shahesmaeili A
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3385-3391. PubMed ID: 34711016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in oesophageal diseases.
    Al Dulaimi D
    Gastroenterol Hepatol Bed Bench; 2014; 7(3):186-9. PubMed ID: 25120902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-33 and Soluble ST2 as Potential Biomarkers of Cancer in Opium Users: A Nested Case-Control Study.
    Firouzabadi N; Javdani K; Dehshahri A
    Iran J Med Sci; 2022 Nov; 47(6):541-548. PubMed ID: 36380972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings.
    Hadji M; Rashidian H; Marzban M; Gholipour M; Naghibzadeh-Tahami A; Mohebbi E; Ebrahimi E; Hosseini B; Haghdoost AA; Rezaianzadeh A; Rahimi-Movaghar A; Moradi A; Seyyedsalehi MS; Shirkoohi R; Poustchi H; Eghtesad S; Najafi F; Safari-Faramani R; Alizadeh-Navaei R; Ansari Moghadam AR; Bakhshi M; Nejatizadeh A; Mahmudi M; Shahid-Sales S; Ahmadi-Simab S; Nabavian O; Boffetta P; Pukkala E; Weiderpass E; Kamangar F; Zendehdel K
    Arch Iran Med; 2021 Mar; 24(3):167-176. PubMed ID: 33878874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study.
    Maino A; Sadeghian S; Mancini I; Abbasi SH; Poorhosseini H; Boroumand MA; Lotfi-Tokaldany M; Jalali A; Pagliari MT; Rosendaal FR; Peyvandi F
    PLoS One; 2023; 18(4):e0283707. PubMed ID: 37074987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.
    Akbari M; Naghibzadeh-Tahami A; Khanjani N; Baneshi MR; Kamali E; Hesampour M; Nazemzadegan B; Haghdoost AA
    Arch Iran Med; 2015 Sep; 18(9):567-71. PubMed ID: 26317596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020.
    Nemati S; Mohebbi E; Toorang F; Hadji M; Hosseini B; Saeedi E; Abdi S; Nahvijou A; Kamangar F; Roshandel G; Ghanbari Motlagh A; Pourshams A; Poustchi H; Haghdoost AA; Najafi F; Sheikh M; Malekzadeh R; Zendehdel K
    Int J Cancer; 2023 Nov; 153(10):1758-1765. PubMed ID: 37548110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
    Collatuzzo G; Etemadi A; Sotoudeh M; Nikmanesh A; Poustchi H; Khoshnia M; Pourshams A; Hashemian M; Roshandel G; Dawsey SM; Abnet CC; Kamangar F; Brennan P; Boffetta P; Malekzadeh R
    Int J Cancer; 2022 Oct; 151(7):1005-1012. PubMed ID: 35489023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Clinical Outcomes of Common Bile Duct Dilation in Patients Who Use Opium.
    Radmard AR; Khorasanizadeh F; Poustchi H; Kooraki S; Mirminachi B; Sharafkhah M; Jafari E; Hashemi Taheri AP; Sotoudehmanesh R; Mohamadnejad M; Malekzadeh R; Merat S
    Am J Med Sci; 2018 Jul; 356(1):39-46. PubMed ID: 30049329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.
    Mirzamohamadi S; HajiAbbasi MN; Roshandel G; Alimadadi M; Mirheidari SB; Ghorbani S; Pourshams A; Zahedi M
    PLoS One; 2024; 19(6):e0300736. PubMed ID: 38848337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opium Use and the Risk of Liver Cancer: A Case-Control Study.
    Marzban M; Mohebbi E; Haghdoost A; Aryaie M; Zahedi MJ; Khazaei Z; Gholizade M; Naghibzadeh-Tahami A
    Cancer Prev Res (Phila); 2023 Jan; 16(1):29-35. PubMed ID: 36149933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study.
    Michaud DS; Liu Y; Meyer M; Giovannucci E; Joshipura K
    Lancet Oncol; 2008 Jun; 9(6):550-8. PubMed ID: 18462995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the Prevalence and Incidence of Opium Abuse and its Association with Coronary Artery Risk Factors in Adult Population in Iran: Findings from Kerman Coronary Artery Disease Risk Factors Study.
    Najafipour H; Masoumi M; Amirzadeh R; Rostamzadeh F; Foad R; Shadkam Farrokhi M
    Iran J Med Sci; 2022 Jul; 47(4):328-337. PubMed ID: 35919081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.